文献速递血栓与止血

儿童住院患者血栓预防的未来构想

Conceptualizing the future of thromboprophylaxis for hospitalized children.
PubMed 文献 · J Thromb Haemost · 2026-09-22

本文为综述,探讨住院儿童血栓预防的现状与未来。文章围绕医院获得性静脉血栓栓塞症(HA-VTE)的预测、出血风险评估、药物安全应用及预防实践的实施,提出以精准医学框架结合人工智能、生物技术和多组学技术,推动个体化风险预测与个性化抗血栓方案。

要点

  • 儿童HA-VTE预防研究在扩展,但临床缺口与障碍持续存在。
  • 精准医学框架强调个体化风险预测与个性化抗血栓方案。
  • 人工智能、生物技术和多组学技术可能在血栓预防中发挥重要作用。

核心结论

  • 未来儿童血栓预防应支持HA-VTE预防研究,促进安全、循证的实践,并最终改善结局。

研究设计与样本

  • 本文为综述,检索范围未在原文中报告。

主要发现

  • 住院儿童血栓预防实践正在演变,新兴的儿童HA-VTE预防研究在扩展,但临床缺口与障碍持续存在。
  • 人工智能、生物技术和多组学技术的快速进步可能在血栓预防中发挥重要作用。
  • 精准医学框架强调应用儿科风险评估模型作为临床决策支持工具,并开发个性化抗血栓方案。

关键数值与推荐

  • 原文未报告具体标准与数值。

临床怎么用

  • 应用儿科风险评估模型作为临床决策支持工具进行个体化风险预测。
  • 开发个性化抗血栓方案。
  • 重视个体与协作管理以指导并成功实施儿童血栓预防实践。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The practice of thromboprophylaxis in hospitalized children is evolving. Emerging research on pediatric hospital-acquired venous thromboembolism (HA-VTE) prevention is expanding, yet clinical gaps and barriers persist. In this review, we conceptualize the future of thromboprophylaxis in children to address current challenges related to the prediction of HA-VTE and assessment of bleeding risk, the safe application of effective pharmacological agents, and implementation of pediatric HA-VTE preventive practices. With rapid advances in artificial intelligence, biotechnology, and multiomics technologies, we consider the major role these technologies can play in thromboprophylaxis. Using a precision medicine framework, we emphasize an individualized risk prediction approach by applying pediatric risk assessment models as clinical decision support tools and developing personalized antithrombotic regimens. In addition, we review some current state-of-the-art experimental pharmacological agents that may be developed in the future. Lastly, we discuss the importance of both individual and collaborative stewardship in guiding and successfully implementing sound thromboprophylaxis practice in children. Overall, we envision the future of pediatric thromboprophylaxis supporting pediatric research on HA-VTE prevention, fostering safe, evidence-based practice, and ultimately improving outcomes.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Huibonhoa RMT, Sochet AA, Faustino EVS, et al. Conceptualizing the future of thromboprophylaxis for hospitalized children. J Thromb Haemost. 2026. PMID: 42772687. doi:10.1016/j.jtha.2026.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。